APOA1 and cancer: Here we demonstrated that an ApoA1 mimetic peptide, employed at higher concentrations than the ones reported in previous studies (Su et al., 2010; Gao et al., 2011, 2012; Ganapathy et al., 2012), can affect Akt signaling and cancer cells sensitivity to platinum.